Dr Tony Badrick
Chief Executive Officer
Tony was Associate Professor, Faculty of Health Sciences and Medicine at Bond University for 4 years before becoming the CEO of the RCPAQAP in 2015. He is an Adjunct Professor School of Pharmacy and Pharmacology, Griffith University, Gold Coast, Honorary Associate Professor, National Centre for Epidemiology and Public Health Australian National University College of Health and Medicine, Honorary Associate Professor, Faculty of Medicine, Bond University, Gold Coast, and Visiting Fellow, Australian Institute for Health Innovation, Macquarie University.
He was also President of the Australasian Association of Clinical Biochemists (2003-2007), Chair of the Faculty of Science RCPA (2012-2018) and is Chair of the Education and Laboratory Management Committee of the Asian Pacific Federation of Clinical Biochemistry, and currently the Chief Examiner of the Faculty of Science of the Royal College of Pathologists of Australasia.
Tony has published over 150 peer-reviewed articles mainly on the themes of Quality Control, Quality Management and Clinical Biochemistry.
Position Quality Manager
Qualifications B App Sc CT(ASC) CT(IAC)
Jenny trained in a number of pathology disciplines including microbiology, haematology and histology at the Queensland State Health Laboratories before commencing at the Royal Brisbane and Womens’ Hospital in the mid 80’s where she began her career in diagnostic cytopathology. Jenny became Cytology Manager at QML Pathology in 1995 and took a strong interest in quality assurance, staff training and continuing education activities. In 2010 Jenny became the Manager for the RCPAQAP Cytopathology Program and oversaw its relocation from Brisbane to Sydney in 2013. An active member of the Australian Society of Cytology for many years, Jenny has held committee positions in both QLD and NSW, including State Councillor (QLD), National Secretary, Chair of the Board of Education and Editor of Cytoletter. She was recently elected as President of the Society and also represents the Society on the National Certification Scheme for Medical Laboratory Scientists Project. While Jenny maintains an active role in the RCPAQAP Cytopathology Program as an Advisory Committee member and has a keen interest in the implementation of the Renewed National Cervical Screening Program – she is a member of the Quality & Safety Monitoring Committee for the Renewal – in 2015 she was appointed Quality Manager for the RCPAQAP.
Joanna has a Bachelor of Applied Science majoring in Microbiology from the University of Technology, Sydney. She has 36 years’ experience in microbiology, quality management, six sigma, lean, training (certificate IV in Training and Assessment) and other business improvement roles in the pharmaceutical and medical industries in organizations such as;
- Johnson & Johnson Medicals
- GlaxoSmithKline (GSK) Pty Ltd
- Cochlear Ltd
- RCPAQAP Pty Ltd
For the past 16 years Joanna has been an accredited Evaluator with the National Business Excellence Awards (now the Australian Organisational Excellence Foundation (AOEF)).
Since 2009 Joanna has held the position of RCPAQAP Biosecurity Program Manager providing Australian and a select number of overseas laboratories with proficiency testing surveys for Security Sensitive Biological Agents (SSBA’s), other potential agents and emerging communicable diseases threats to Australia.
Joanna is Chair of the Professional Development Standing Committee (PDSC) for the Association of Biosafety for Australia and New Zealand (ABSANZ). The PDSC offer training to ABSANZ members and other overseas association members in collaboration with the International Federation of Biosafety Association (IFBA) who offer the first internationally accredited examinations in biosafety, biosecurity and biocontainment. Joanna also serves as a member of the ABSANZ Board of Directors.
Dr Louise Wienholt
Manager – Business Development and Blood Disciplines
Louise is the Manager of Commercial Strategy and Business Development at the Royal College of Pathologists of Australasia Quality Assurance Programs (RCPAQAP) and a Lecturer at the Sydney Medical School, University of Sydney. She has a Bachelor of Biomedical Science, a Master’s of Science in Medicine specialising in coeliac disease, a Doctorate of Business Administration focusing on quality in diagnostic pathology testing and is a Fellow of the Faculty of Science of the Royal College of Pathologist of Australasia in the discipline of Immunopathology.
Louise is a member of a number of professional boards and organisations including Australian Society of Clinical Immunology and Allergy (ASCIA), the Medical Advisory Council of Coeliac Society of Australia and the Sydney Business School. She has held a number of management roles in Immunology and Infectious Serology and has authored over 20 peer reviewed publications.
Dr Martin P Horan
Manager – Molecular Genetics
PhD in Molecular Genetics – Cardiff University UK
BSc (Hons) Biomedical Sciences – University of Sunderland UK
Martin has an extensive research background in human molecular genetics. In particular, he has focused on developing clinical diagnostic applications and has successful patents for novel PCR and sequencing based genetic disease testing strategies. His in-depth studies have further aimed to understand how cellular mechanisms are involved in human disease development and progression. To gain a greater understanding of underlying disease processes, Martin studied various human diseases including the cancer syndrome of neurofibromatosis type 1, clinical short stature, cardiovascular disease, breast cancer, leukaemia, Rett syndrome and mitochondrial malfunction in age-related disorders (including prostate cancer, Alzheimer disease, Parkinson disease and type 2 diabetes). He has lectured at Universities in the UK and in Australia and managed and supervised clinical and postdoctoral researchers as well as PhD, Medical and Honours students in studying human genetic disease mechanisms.